Serum Amyloid A (SAA)

PDB ID: 4IP8. Source: RCSB Protein Data Bank. For illustration purposes only.

VeriLumenTM 血清淀粉样蛋白A

The VeriLumenTM SAA Rapid Test is an in vitro fluorescence immunochromatographic assay for the quantitative detection of serum amyloid A (SAA) in human whole blood, plasma, or serum. SAA is an acute-phase protein that increases rapidly in response to inflammation and is used as a sensitive, non-specific marker of inflammatory activity and tissue injury. The fluorescence-based assay provides rapid quantitative results to support timely clinical evaluation in laboratory and point-of-care settings.

This test is intended to assist in the assessment of inflammatory and infectious conditions, including bacterial infections and systemic inflammatory responses, supporting clinical evaluation and patient management decisions when interpreted together with clinical findings and other laboratory data. Quantitative SAA measurement may also aid in monitoring disease progression and response to treatment in acute care settings.

Ref. Code 808161
Analyte Serum amyloid A (SAA)
Format Fluorescence lateral flow immunoassay (cassette format)
Diagnostic Readout Quantitative
Time to Result 5 minutes
Measuring Range 2.0–200 mg/L
Reference Value 10.0 mg/L
R2 ≥ 0.95
Storage Conditions 2–30°C
Shelf Life 18 months
Certificate CE, NMPA
Sample Types Human whole blood, plasma or serum
Sample Volume 10μL
Collection Method Venous blood
Sample Stability Stable for testing within 1 hour at room temperature (as validated)
Acceptable Anticoagulants EDTA / Heparin / Citrate (as applicable)
Notes on Handling Specimens should be collected and handled using standard laboratory procedures. Use fresh samples when possible and avoid hemolyzed, lipemic, or contaminated specimens.
Detection Method Quantitative fluorescence immunochromatography
Antibody Format Monoclonal / sandwich
Signal Generation Fluorescence signal (fluorescent-labeled immunochromatography)
Reading Method Instrument-based
Mechanism The assay is based on a fluorescence immunochromatographic sandwich principle, in which serum amyloid A (SAA) present in the sample binds to specific fluorescently labeled anti-SAA antibodies during capillary migration along the membrane. The resulting antigen–antibody complexes are captured by immobilized antibodies at the test region, and the emitted fluorescence signal is measured and correlated with the SAA concentration in the specimen.
Tests per Kit 10/25/50 Tests
Dimension of Kit Box 21 × 13.5 × 8 cm
Kits per Carton 48 Kits
Tests per Carton (Bulk) 1200 Tests
G.W. per Carton (Boxed) 23.2 kg
G.W. per Carton (Bulk) 26.2 kg
Carton Dimension 67 × 57.5 × 39 cm
Carton Volume 0.15 CBM
Packaging Format Individual sealed test kits / bulk configuration (as applicable)
Items Included - Test cassette
- Desiccant
- Sample diluent
- ID chip
- Instructions for Use
Storage & Shipping Conditions Standard ambient transport; store according to product label requirements

Let’s advance POCT diagnostics together

Shenzhen Kang Sheng Bao
Biotechnology Co., Ltd.

Second Floor, Block 3, Anda

Electronic Industrial Park,

Fuhai, Bao’an District,

518103 Shenzhen, 

Guangdong Province, PRC

 

+86 0755 27417763 

 

info@ksbbiotech.com